Publications by authors named "T Roderick Docking"

Article Synopsis
  • Analyzing omics data types separately can limit the ability to find important variations that are consistent across different assays.
  • Integrating multiple omics data types into one model can enhance statistical power, but it poses challenges due to the different levels at which these data are measured.
  • The iNETgrate package was developed to integrate transcriptome and DNA methylation data into a single gene network, showing improved prognostic capabilities over standard clinical methods in five independent datasets.
View Article and Find Full Text PDF

Integrating multi-omics data in one model can increase statistical power. However, designing such a model is challenging because different omics are measured at different levels. We developed the iNETgrate package (https://bioconductor.

View Article and Find Full Text PDF

We recently described a 16-gene expression signature for improved risk stratification of acute myeloid leukemia (AML) patients called the AML Prognostic Score (APS). A subset of APS-high-risk AML patients showed increased levels of focal adhesion kinase (FAK), encoded by the Protein Tyrosine Kinase 2 (PTK2) gene, which was correlated with RUNX1 mutations. RUNX1 mutant cells are more sensitive to PTK2 inhibitors.

View Article and Find Full Text PDF

Integration of orthogonal data could provide new opportunities to pinpoint the underlying molecular mechanisms of hematologic disorders. Using a novel gene network approach, we integrated DNA methylation data from The Cancer Genome Atlas ( = 194 cases) with the corresponding gene expression profile. Our integrated gene network analysis classified AML patients into low-, intermediate-, and high-risk groups.

View Article and Find Full Text PDF

As more clinically-relevant genomic features of myeloid malignancies are revealed, it has become clear that targeted clinical genetic testing is inadequate for risk stratification. Here, we develop and validate a clinical transcriptome-based assay for stratification of acute myeloid leukemia (AML). Comparison of ribonucleic acid sequencing (RNA-Seq) to whole genome and exome sequencing reveals that a standalone RNA-Seq assay offers the greatest diagnostic return, enabling identification of expressed gene fusions, single nucleotide and short insertion/deletion variants, and whole-transcriptome expression information.

View Article and Find Full Text PDF